Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Indian Drug Makers Increase Nutraceutical Activity

This article was originally published in PharmAsia News

Executive Summary

Several Indian drug makers are expanding their nutraceutical products to take advantage of an expected explosion in the market. The pharmaceutical industry estimates the nutraceutical segment of medicine to be worth about $400 million in India, a major part of a $7 billion health care sector. An Ernst & Young partner questioned, however, whether the segment also should include ayurvedic and herbal products, which in India are considered drugs for regulatory purposes. Those products are expected to reach $190 billion in sales by 2010. Among drug makers seeking to expand are Elder Pharma, Glenmark, Plethico, Troikaa and Wockhardt. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts